Expert issues verdict on Pedro Neto passing Arsenal medical after Wolves ‘green light’
Pedro Neto’s recent knee injury history will not stand in the way of him passing a potential Arsenal medical.
That is the view of medical expert Ben Dinnery, who runs the Premier Injuries site and has a background in injury and data analysis.
The Athletic reported on Monday (22 August) that the Gunners are in talks with Wolves over a possible deal for Neto.
The 22-year-old Portuguese winger, who in March signed a new contract until 2027, returned from a knee injury in February that saw him sidelined for close to a year.
Wolves recently broke their transfer record to bring Neto’s countryman Matheus Nunes, 23, to Molineux.
They have also been linked with a number of other attacking options, with the end of the summer transfer window now in sight.
Dinnery suggests that Wolves’ activity in the market may effectively be a “green light” for Neto to move to complete a switch to the Emirates.
“This is something we at Premier Injuries covered in pre-season,” he told Football Insider’s Adam Williams.
“There was a lot of interest ahead of his return to that Wolves team.
“If I recall correctly, he was in that Wolves team from around February time. Everyone expected him to come back into the team and really bang for the second half of the season, but that didn’t really happen.
“He picked up a few knocks and niggles, which is to be expected after such a long-term injury.
“The knee issue itself was unfortunate but there will be no lasting effects with regards to that. With a good pre-season under his belt, I think he should have a good campaign.
“He has been heavily linked with Arsenal and Wolves have just signed a couple of players. The talk is that will effectively green-light the sale of Neto.
“When we talk about medicals, the recruitment side of things won’t leave any stone unturned with regards to that. So, I am fully confident that this pre-existing injury won’t have any long-term or lasting impact.”
In other news, finance guru claims Arsenal have “no limit” as new Japanese deal agreed.